Home World News Extended Anticoagulation with Reduced-Dose Non-inferior to Full-Dose Apixaban for the Prevention of... World News Extended Anticoagulation with Reduced-Dose Non-inferior to Full-Dose Apixaban for the Prevention of Recurrent VTE in Patients with Active Cancer By Ogkologos - April 29, 2025 894 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the API-CAT study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Trial Should Change Care for AIDS-Related Kaposi Sarcoma in Sub-Saharan Africa March 10, 2020 Pivotal Role of the Institutional Molecular Tumour Board in Evaluating the... September 10, 2021 ESMO World Congress on Gastrointestinal Cancer 2022 Barcelona, Spain 29 June... June 17, 2022 6 Habits That Can Help You Feel More in Control of... November 30, 2022 Load more HOT NEWS Former WNBA Player, Current Georgia Tech Coach Tasha Butts Diagnosed with... Ovarian, bowel and non-Hodgkin’s lymphoma treatments approved for NHS use in... EMA Recommends Approval of the Marketing Authorisation for Tagraxofusp COVID-19 Vaccines Are Safe for People Receiving Cancer Immunotherapy, Study Confirms
